Friday, July 31, 2009

New Grant by AAE Foundation Awarded to University of Texas Health Science Center at Houston

Aims to Enhance Endodontics' Dental School Presence

CHICAGO -- The AAE Foundation announced that it has awarded its first Endowed Faculty Matching Grant to the endodontic department of the University of Texas Health Science Center at Houston.

The $100,000 contribution, matched by gifts from generous alumni, will fund the John R. Ludington Jr., D.D.S., M.S.D. Distinguished Professorship in Endodontics. The Ludington Professor will serve as the program’s predoctoral director of endodontics. The department is chaired by Samuel O. Dorn, D.D.S.

“We hope this grant will stimulate fundraising efforts at endodontic departments across the country,” said Foundation President A. Eddy Skidmore. “Our goal is to ensure that every dental student has the opportunity to learn about endodontics from a specialist and that endodontics is a significant presence in dental schools across the country.”

The Endowed Faculty Matching Grant was introduced in 2008. It provides an annual opportunity for endodontic programs to receive up to $100,000 to support an endowed faculty position at their institutions. The intention of the AAE Foundation program is to promote academic excellence and to help ensure that endodontics will be taught by specialists. The grant is also intended to boost the recipient institutions’ fundraising capacity.

The Endowed Faculty Matching Grant is one of a constellation of funding initiatives that include competitive grants for research, support to endodontic educators, and Fellowship awards for endodontic students and clinicians who seek to pursue a career in education.

# # #

The AAE Foundation is the philanthropic arm of the American Association of Endodontists. Its mission is to advance research and education in the specialty of endodontics. It is the only organization that provides support to every accredited endodontic program in the United States and Canada. The Foundation invests approximately $1 million in the specialty annually.

The American Association of Endodontists, headquartered in Chicago, represents more than 7,000 members worldwide, including approximately 95 percent of all eligible endodontists in the United States. The Association, founded in 1943, is dedicated to excellence in the art and science of endodontics and to the highest standard of patient care.

Wednesday, July 29, 2009

“Red Flags Rule” Delayed until November 1, 2009

The Federal Trade Commission (FTC) has again delayed implementation of the so-called “Red Flags Rule” until November 1, 2009


To assist small businesses and other entities, the Federal Trade Commission staff will redouble its efforts to educate them about compliance with the "Red Flags" Rule and ease compliance by providing additional resources and guidance to clarify whether businesses are covered by the Rule and what they must do to comply. To give creditors and financial institutions more time to review this guidance and develop and implement written Identity Theft Prevention Programs, the FTC will further delay enforcement of the Rule until November 1, 2009.

Tuesday, July 28, 2009

FDA Issues Final Regulation on Dental Amalgam

FDA Issues Final Regulation on Dental Amalgam

The U.S. Food and Drug Administration today issued a final regulation classifying dental amalgam and its component parts – elemental mercury and a powder alloy—used in dental fillings. While elemental mercury has been associated with adverse health effects at high exposures, the levels released by dental amalgam fillings are not high enough to cause harm in patients.

The regulation classifies dental amalgam into Class II (moderate risk). By classifying a device into Class II, the FDA can impose special controls (in addition to general controls such as good manufacturing practices that apply to all medical devices regardless of risk) to provide reasonable assurance of the safety and effectiveness of the device.

The special controls that the FDA is imposing on dental amalgam are contained in a guidance document that contains, among other things, recommendations on performance testing, device composition, and labeling statements.

Specifically, the FDA recommended that the product labeling include:

* A warning against the use of dental amalgam in patients with mercury allergy;
* A warning that dental professionals use adequate ventilation when handling dental amalgam;
* A statement discussing the scientific evidence on the benefits and risk of dental amalgam, including the risks of inhaled mercury vapor. The statement will help dentists and patients make informed decisions about the use of dental amalgam.

Dental amalgam is a “pre-amendment device,” which means that it was in use prior to May 28, 1976, when the FDA was given broad authority to regulate medical devices. That law required the FDA to issue regulations classifying pre-amendment devices according to their risk into class I, II, or III. Although the FDA previously had classified the two separate parts of amalgam – elemental mercury and the metal powder alloy – it had not issued a separate regulation classifying the combination of the two, dental amalgam. During this time, however, dental amalgam has been subject to all applicable provisions of the law.

Today’s regulation also reclassifies the mercury component of dental amalgam from Class I (low risk) to Class II (moderate risk).

Over the past six years, the FDA has taken several steps to assure that the classification of dental amalgam is supported by strong science.

In 2002, the agency issued a proposed rule to classify dental amalgam and identify any special controls necessary for its safe and effective use.

Due to a high number of comments on that rule, the agency held an advisory committee meeting in 2006, inviting dental and neurology experts to review existing scientific data on dental amalgam, especially with regard to its toxicity in pregnant women and children.

The agency drafted a review of recent and relevant peer-reviewed scientific literature on exposure to dental amalgam mercury. The advisory committee asked that the agency conduct an even deeper review of the scientific literature on this topic. In all, the agency considered some 200 scientific studies.

On April 28, 2008, the FDA reopened the comment period on the 2002 proposed classification in order to elicit the most up-to-date comments and information related to classification of dental amalgam. Today’s rule reflects the years of agency review on this topic.

FDA’s Web site on dental amalgam:
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DentalProducts/DentalAmalgam/default.htm

Monday, July 27, 2009

Chris Eubank hopes to cure lisp with £30,000 of dentistry

He is getting some veneers and they are guaranteed for life?MJ

Chris Eubank, the retired boxing champion, is having £30,000 of dental treatment to cure his famous lisp.

Read the rest on the Daily Telegraph web page.

Sunday, July 26, 2009

New treatment for receding gums works long-term

Reuters Health

Thursday, July 23, 2009

By Amy Norton

NEW YORK (Reuters Health) - A therapy that helps regenerate receding gum tissue seems to hold up over the long term -- and may offer patients an alternative to more-extensive dental surgery, a small study finds.

One option for treating severe gum disease is surgery to replace tissue lost from around the teeth and their roots. Traditionally, that has meant taking tissue from the roof of the patients' mouth and "grafting" it onto the receding gums.

The surgery is effective, but requires stitches in the roof of mouth and leaves patients in pain afterward.

In the new study, published in the Journal of Periodontology, researchers at Tufts University in Boston looked at the longer-term results of an alternative procedure known as guided tissue regeneration, or GTR.

The study looked at a specific GTR technique, developed at Tufts, that involves drawing blood from the patient to retrieve blood cells known as platelets, which are rich in proteins called growth factors that aid in tissue repair and wound healing.

A membrane made of collagen is soaked in the platelets then sutured over the receding tooth root.

Drs. Terrance J. Griffin and Wai S. Cheung followed six patients who had had the procedure done on a total of 37 teeth. After six months, new tissue was completely covering the roots of two-thirds of the treated teeth. After three years, 57 percent still had complete root coverage.

The long-term results are comparable to what is seen with traditional graft surgery, Griffin told Reuters Health.

"The new treatment reduces pain and discomfort, offers excellent root coverage, and results in increased patient satisfaction with the results," he said. "We now know that it is stable after three years."

The treatment is not yet widely available, according to Griffin, though it is becoming better known.

He noted that receding gums, the condition targeted by this particular treatment, is just one form of gum disease. "The good news is that researchers are making strides in tissue regeneration treatments."

SOURCE: Journal of Periodontology, July 2009.

Friday, July 24, 2009

Feasibility of Osteoporosis Screening by Dual-Energy Radiographic Absorptiometry of the Phalanx

Priya Ganapathya and Julie A. Skipper
Journal of Clinical Densitometry
Volume 12, Issue 2, April-June 2009, Pages 251-259

Abstract

A new dual-energy radiographic absorptiometry–based technique is presented as a cost-effective method for mass osteoporosis screening. Designed for use in a dental health care setting, we propose a method and device for bone mineral density (BMD) assessment using the middle phalanx of the 3rd digit as our anatomical measurement site. Our 2-staged project includes the development of the prototype to carry out the measurement and the execution of a small pilot study to determine the efficacy of the method and device. Fifty subjects from the general adult population (age range: 25–82 yr), wherein 10 normal subjects (5 females and 5 males) and 40 target group subjects (30 females and 10 males) who were at risk for osteoporosis (as assessed qualitatively through questionnaire responses) were evaluated with our method. The BMD values obtained from the normal and target groups were significantly different (p < 0.0001). Phantom measurements to determine the bias and coefficient of variation of the technique yielded values of 1.9% and 7%, respectively. The proposed technique could provide a relatively inexpensive and widely available means for mass osteoporosis screening. Further validation of this method, to include comparison to a gold standard, such as dual-energy X-ray absorptiometry, is warranted.

Thursday, July 23, 2009

Align Technology Provides Update on Patent Litigation with Ormco Corporation

SANTA CLARA, Calif., July 21 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN - News) today provided an update on the a lawsuit brought by Ormco Corporation (Ormco) against Align Technology, Inc. (Align) in the U.S. District Court for the Central District of California (District Court), which was tried by jury June 9 through June 25, 2009.

As previously disclosed, on June 26, 2009, the jury delivered a verdict against Align. Ormco alleged that Align infringed claims of Ormco's 6,616,444 patent. Align claimed non-infringement, invalidity, as well as unenforceability of the patent and equitable defenses. The jury found the claims asserted by Ormco in the 6,616,444 patent to be infringed and valid. The jury also issued an advisory verdict that Ormco did not engage in prosecution laches or unclean hands, equitable defenses raised by Align. The jury only determined liability. Any monetary damages will be determined in a later trial, which has not been schedule, but would likely occur in early 2010. The jury verdict does not preclude Align from selling its Invisalign System. We have not accrued any liability for the judgment related to the Ormco litigation as such amounts are not reasonably estimable at this time. This is due to a number of factors, including: that the Court has not yet entered judgment; that discovery regarding possible damages is a lengthy and time consuming process involving testimony of experts and has not yet begun; and that determining a reasonable royalty rate is highly fact specific and there are many complicated factors to consider in this case.

The Court requested and has received briefing on the equitable defenses raised by Align and is expected to rule on the equitable defenses later this week. Align believes the facts and the law do not support the jury's findings of infringement and validity and therefore has filed a motion for judgment as a matter of law on all issues seeking to set aside the jury's verdict of liability. The Court has set a hearing on our motion for August 3, 2009, after which the Court is expected to enter judgment. Depending on the judgment entered by the Court, we may file various post-trial motions and if unsuccessful, we intend to appeal the liability decision and request a stay of the damages phase of the case pending appeal

On July 13, 2009, Ormco filed a motion for permanent injunction against Align seeking to enjoin the sale of the Invisalign System through the January 2010 expiration of the 6,616,444 patent, as well as other injunctive relief including the destruction of all material, including software, created by Align from September 2003 to the present, the discontinuation of certification programs and the decertification of doctors certified from September 2003 to the present and the destruction of sales representatives' records developed during this time period. The Court has scheduled a hearing on the motion for permanent injunction for August 17, 2009. Ormco seeks unusual injunctive relief that we believe is unwarranted and not supported by the law or facts of the case. Align will contend that an injunction would cause irreparable harm to Align, its employees and those doctors who include Invisalign as a large part of their practice, and would interrupt patient treatment and services currently underway. In addition, a balancing of hardships weighs heavily in Align's favor as the issuance of the injunction would require Align the cease the sale of its sole product, the Invisalign System, while the denial of the injunction does not harm Ormco. Finally, any harm Ormco claims to have suffered would be sufficiently compensated by money damage. For these reasons, we strongly believe that Ormco's motion for a permanent injunction should be denied and we will vigorously oppose the motion. In the unlikely event that the Court grants a permanent injunction, we would immediately appeal to the Federal Circuit Court of Appeals and seek to stay the injunction.

Ormco Patent Litigation Background Previously Disclosed:

Align has had ongoing patent litigation with Ormco, since 2003 when Ormco sued Align for patent infringement and Align won a sweeping summary judgment. Ormco appealed that decision and in August 2007 the Federal Circuit Court of Appeals ruled that 86 of Ormco's 92 claims (related to 6,616,432, '243, '861 and '444 patents) were invalid and not infringed by Align. Ormco pursued the six remaining claims, which relate generally to a process of gathering and organizing tooth data, in the lawsuit against Align in the U.S. District Court for the Central District of California.

Wednesday, July 22, 2009

FDA Urges Consumers Not to Purchase or Use Certain Gel-Filled Teethers Products found to contain bacteria; voluntary na

FDA NEWS RELEASE

For Immediate Release: July 18, 2009

Media Inquiries: Peper Long, 301-796-4671, mary.long@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
FDA Urges Consumers Not to Purchase or Use Certain Gel-Filled Teethers
Products found to contain bacteria; voluntary nationwide recall underway

Luv N’ Care Ltd. of Monroe, La., is initiating a nationwide recall of gel-filled teethers with the brand names “Nuby,” “Cottontails” and “Playschool,” because the liquid inside the gel-filled teethers has been found to contain Bacillus subtilis and Bacillus circulans bacteria in the gel.

Although these bacteria generally do not cause illness in adults, infants and children with weakened immune systems can experience stomach pain, vomiting, diarrhea, and uncommonly more serious disease, if the teether becomes punctured and they ingest the liquid gel.

Consumers who have teethers with the brand names and UPC Codes listed below should immediately stop using them and discard or return them to the place of purchase for a full refund.

Get the brands on the FDA web site

Monday, July 20, 2009

Trimira™ Offers Online Library of Oral Cancer Images


HOUSTON, TX: July 15, 2009 Trimira™ LLC, manufacturers of the Identafi 3000™ Oral Cancer Screening Device, have developed the Trimira Clinical Image Library, a comprehensive online catalog of clinical photographs taken by leading scientists and researchers. The images show a diverse array of lesions in various locations in the oral cavity. Access to the library is free and available at www.trimira.net. A demo version can be accessed by anyone; the full library is available only to registered Trimira customers.

Photographs in the Trimira Clinical Image Library were taken under the three proprietary multispectral lights produced by the Identafi 3000, providing optimal visualization of the lesions. Images are categorized by location in the mouth, type of dysplasia, and appearance under each light wavelength. Trimira plans to increase the number and diversity of photographs in the coming months.


The Trimira Identafi 3000 is a small, cordless, affordable handheld device that helps clinicians effectively detect early cancers not visible to the naked eye. The device uses a three-wavelength optical fluorescence and reflectance technology patented by Trimira LLC of Houston. The Identafi 3000 was developed in collaboration with scientists at M.D. Anderson Cancer Center, Rice University, and British Columbia Cancer Research Center, and is now available through dealers nationwide. Trimira LLC is a subsidiary of Remicalm LLC, a privately held medical device and optical imaging company.

Sunday, July 19, 2009

Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT).

Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT).
Vescovi P, Manfredi M, Merigo E, Meleti M, Fornaini C, Rocca JP, Nammour S.

Oral Medicine and Laser-Assisted Surgery Unit- Section of Dentistry - Department of ENT/Dental/Ophtalmological and Cervico-Facial Sciences, EMDOLA (European Master Degree on Oral Laser Applications) - University of Parma, Parma, Italy, paolo.vescovi@unipr.it.

Osteonecrosis of the jaw (ONJ) in patients on long-term bisphosphonate Therapy (BPT) has been reported with increasing frequency in literature over the past 4 years. Therapy for this condition is still a dilemma. Temporary suspension of BPT offers no short-term benefits; hyperbaric oxygen has no proven efficacy and therefore is not recommended. Intermittent or continuous antibiotic therapy with surgical debridement can be beneficial to palliate the symptoms. Er:YAG laser can be used to eliminate necrotic bone portions by partial or total resection as an alternative to conventional rotary devices. In our study, 91 patients affected by ONJ-BP lesion, for a total of 115 ONJ sites were observed between January 2004 and May 2008 (Department of Odontostomatology, University of Parma). Fifty-five ONJ sites were considered for this study in four different groups, retrospectively identified on the basis of treatment performed (G1-G4). G1: 13 ONJ-BP sites were treated with medical therapy (amoxicillin 1gr x 3/die per os with metronidazole 250 mg x 2/die per os) for at least 2 weeks; G2: 17 ONJ-BP sites received medical treatment in association with cycles of low-level laser therapy (LLLT) applications performed using an Nd:YAG laser (1,064 nm) once a week for 2 months; G3: 13 ONJ-BP sites were surgically treated (sequestrectomy of necrotic bone, debridement, corticotomy/surgical removal of alveolar and/or cortical bone); G4: 12 ONJ-BP sites were treated with surgical therapy performed using an Er:YAG laser (2,940 nm) in association with LLLT. Clinical success has been defined for each treatment performed as: (a) complete mucosal healing free from signs and symptoms (classified as stage "0") or (b) transition from a higher to a lower stage (Ruggiero staging) for at least 3 months. All the ONJ-BP sites treated with Er:YAG laser (G4 group) had a clinical improvement (100%) and 87.5% of sites had a complete mucosal healing with a mean follow-up of 13 months. The result obtained in the G4 is extremely significant in comparison with those obtained by medical treatment alone or in a traditional surgical approach. Thanks to the high degree of affinity of this wavelength for water and hydroxyapatite, both soft and bone tissues can be easily treated. This technique can also be used for conservative operations whereby necrotic bone is vaporized until healthy bone is reached. In addition, an additional advantage of the Er:YAG laser is its bactericidal and possible biostimulatory action, accelerating the healing of both soft tissues and bone tissues, in comparison to conventional treatments. In conclusion, from our experience, it is possible to observe that an early conservative surgical approach with Er:YAG laser associated with LLLT, for BP-induced ONJ could be considered as more efficient in comparison with medical therapy or other conventional techniques.

Saturday, July 18, 2009

Henry Schein signs distribution deal with Dentatus

Henry Schein signs distribution deal with Dentatus

Health care products and services company Henry Schein Inc. said Tuesday that it signed a five-year deal to become the exclusive distributor of Dentatus' narrow body dental implants in North America, Australia and New Zealand.

Friday, July 17, 2009

Diets bad for the teeth are also bad for the body

Beyond the immediate distress, dental pain may portend future medical problems

Dental disease may be a wake-up call that your diet is harming your body.

"The five-alarm fire bell of a tooth ache is difficult to ignore," says Dr. Philippe P. Hujoel, professor of dental public health sciences at the University of Washington (UW) School of Dentistry in Seattle. Beyond the immediate distress, dental pain may portend future medical problems. It may be a warning that the high-glycemic diet that led to dental problems in the short term may, in the long term, lead to potentially serious chronic diseases.

Hujoel reviewed the relationships between diet, dental disease, and chronic systemic illness in a report published July 1 in the Journal of Dental Research. He weighed two contradictory viewpoints on the role of dietary carbohydrates in health and disease. The debate surrounds fermentable carbohydates: foods that turn into simple sugars in the mouth. Fermentable carbohydrates are not just sweets like cookies, doughnuts, cake and candy. They also include bananas and several tropical fruits, sticky fruits like raisins and other dried fruits, and starchy foods like potatoes, refined wheat flour, yams, rice, pasta, pretzels, bread, and corn.

One viewpoint is that certain fermentable carbohydrates are beneficial to general health and that the harmful dental consequences of such a diet should be managed by the tools found in the oral hygiene section of drugstores. A contrasting viewpoint suggests that fermentable carbohydrates are bad for both dental and general health, and that both dental and general health need to be maintained by restricting fermentable carbohydrates.

The differing perspectives on the perceived role of dietary carbohydrates have resulted in opposing approaches to dental disease prevention, Hujoel notes, and have prompted debates in interpreting the link between dental diseases and such systemic diseases as obesity, diabetes, and some forms of cancer.

Over the past twenty years or so, Hujoel says, people have been advised to make fermentable dietary carbohydrates the foundation of their diet. Fats were considered the evil food. A high-carbohydrate diet was assumed to prevent a number of systemic chronic diseases. Unfortunately, such a diet - allegedly good for systemic health - was bad for dental health. As a result, cavities or gingival bleeding from fermentable carbohydrates could be avoided only – and not always successfully, as Hujoel points out -- by conscientious brushing, fluorides, and other types of dental preventive measures. When these measures are not successful, people end up with cavities and gum disease.

Hujoel observed that the dental harms of fermentable carbohydrates have been recognized by what looks like every major health organization. Even those fermentable carbohydrates assumed to be good for systemic health break down into simple sugars in the mouth and promote tooth decay. All fermentable carbohydrates have the potential to induce dental decay, Hujoel notes.

But what if fermentable carbohydrates are also bad for systemic health? Hujoel asks. What if dietary guidelines would start incorporating the slew of clinical trial results suggesting that a diet low in fermentable carbohydrates improves cardiovascular markers of disease and decreases body fat? Such a change in perspective on fermentable carbohydrates, and by extension, on people's diets, could have a significant impact on the dental profession, as a diet higher in fat and protein does not cause dental diseases, he notes. Dentists would no longer be pressed to recommend to patients diets that are bad for teeth or remain mum when it comes to dietary advice. Dentists often have been reluctant, Hujoel says, to challenge the prevailing thinking on nutrition. Advising patients to reduce the amount or frequency of fermentable carbohydrate consumption is difficult when official guidelines suggested the opposite.

The close correlation between the biological mechanisms that cause dental decay and the factors responsible for high average levels of glucose in the blood is intriguing. Hujoel explains that eating sugar or fermentable carbohydrates drops the acidity levels of dental plaque and is considered an initiating cause of dental decay.

"Eating these same foods, he says, is also associated with spikes in blood sugar levels. There is fascinating evidence that suggests that the higher the glycemic level of a food, the more it will drop the acidity of dental plaque, and the higher it will raise blood sugar. So, possibly, dental decay may really be a marker for the chronic high-glycemic diets that lead to both dental decay and chronic systemic diseases. This puts a whole new light on studies that have linked dental diseases to such diverse illnesses as Alzheimer's disease and pancreatic cancer."

The correlations between dental diseases and systemic disease, he adds, provide indirect support for those researchers who have suggested that Alzheimer's disease and pancreatic cancer are due to an abnormal blood glucose metabolism.

The hypotheses on dental diseases as a marker for the diseases of civilization were postulated back in the mid-20th century by two physicians: Thomas Cleave and John Yudkin. Tragically, their work, although supported by epidemiological evidence, became largely forgotten, Hujoel notes. This is unfortunate, he adds, because dental diseases really may be the most noticeable and rapid warning sign to an individual that something is going awry with his or her diet.

"Dental problems from poor dietary habits appear in a few weeks to a few years," Hujoel explains. "Dental improvement can be rapid when habits are corrected. For example, reducing sugar intake can often improve gingivitis scores (a measurement of gum disease) in a couple of weeks. Dental disease reveals very early on that eating habits are putting a person at risk for systemic disease. Because chronic medical disease takes decades to become severe enough to be detected in screening tests, dental diseases may provide plenty of lead-time to change harmful eating habits and thereby decrease the risk of developing the other diseases of civilization."

In planning a daily or weekly menu, Hujoel suggests: "What's good for your oral health looks increasingly likely to also benefit your overall health."

Thursday, July 16, 2009

The Guru Subscription Plan

I use Guru everyday in my office and having Guru TV running in the reception area. MJ

Introducing The Guru Subscription Plan

We are very pleased to announce the availability of the Guru Subscription Plan for Fall 2009! We are excited to roll out this new pricing option for Guru, the premier patient education tool for the entire dental office. Guru is a total solution for patient education in your office and beyond that no other tool provides, and Guru completes any DENTRIX practice management package or Henry Schein product purchase. Using the spectacular animations and images in Guru, your treatment plans become even more engaging, educational, and compelling to patients. With Guru, you can see better patient compliance with treatment, greater results for your practice, and accelerated potential to grow your practice revenue with more patients and more comprehensive treatments! Additionally, GuruTV engages your patients in the reception area even before they sit down in your chair. What could be a better complement to saving time and money with your DENTRIX practice management system?

Because we're so sure Guru is the obvious choice to add value your practice management software, we've constructed the Subscription Plan with a 90 day satisfaction guarantee, minimal initial investment, and to be "bundle-able" with other product purchases. Contact your Sales representative today for more information.

The Guru Subscription Plan features:

* Only $49.99/mo. with a $499 install/training fee will get Guru in your office TODAY
* 4 Courses of in-depth online training with a Certified Guru Practice Consultant
* GuruTV for your reception area available at separate purchase of $499
>

This criminally easy option will get you and Guru educating your patients in no time at all! Next time your regional sales rep visits, ask about the all-new Guru101 DVD (available July 2009), which will introduce you to Guru's powerful educational features in just six minutes. If you decide Guru is right for your practice, the DVD includes a payment link and install/activation Code for your immediate use. On the Guru Subscription plan, there's no shipment time or wait to begin implementation. You'll immediately be eligible for 4 courses of online training with your Certified Guru Practice Consultant, and immediate use of Guru!

And there's more to come! Guru is updated monthly with new images and enhancements. Visit www.HowDoYouGuru.com OR please direct all inquiries to:

Lee Allen, Guru Product Marketing Manager
lee.allen@henryschein.com
360.931.5171

Jeff Jackson, Guru Product Manager
jeff.jackson@henryschein.com

Holly Holm, Guru Marketing Communications
holly.holm@henryschein.com
801.847.4437

Wednesday, July 15, 2009

Customized mandibular orthotics in the prevention of concussion/mild traumatic brain injury in football players: a preliminary study

Dental Traumatology
Published Online: 9 Jul 2009
© 2009 John Wiley & Sons A/S

G. Dave Singh 1 , Gerald J. Maher 2 , Ray R. Padilla 3
1 Director of Continuing Education, SMILE Foundation, Chatsworth, CA, USA ; 2 President, Mahercor Labs, LLC, South Weymouth, MA, USA ; 3 Lecturer, UCLA School of Dentistry, Los Angeles, CA, USA

ABSTRACT
Abstract –

Background/Aim: It is accepted that sports mouthguards decrease the incidence of dental injuries in athletes, but the value of oral orthotics in the prevention of concussion/mild traumatic brain injuries in footballers remains contentious. However, previous investigations have primarily studied non-customized mouthguards without dental/temporo-mandibular joint examinations of the subjects. Therefore, the aim of this study is to determine whether the use of a customized mandibular orthotic after temporo-mandibular joint assessment reduces the incidence of concussion/mild traumatic brain injuries in high-school football players.

Materials and methods: Using a longitudinal, retrospective design, data were collected from a cohort of football players (n = 28) over three seasons using a questionnaire. The mean age of the sample prior to the use of the customized mandibular orthotic was 17.3 years ± 1.9. Prior to deployment, dental records and temporo-mandibular joint evaluations were undertaken, as well as neurocognitive assessment, including history of concussion/mild traumatic brain injuries. After establishing optimal jaw position, a customized mandibular orthotic was fabricated to the new spatial relations.

Results: The mean age of the sample after three seasons was 19.7 years ± 2.0. Prior to the use of the customized mandibular orthotic, the mean self-reported incidence of concussion/mild traumatic brain injuries was 2.1 ± 1.4 concussive events. After the deployment of the customized mandibular orthotic the number of concussive events fell to 0.11 ± 0.3 with an odds ratio of 38.33 (95% CI 8.2–178.6), P < 0.05.

Conclusion: The preliminary results of this study suggest that a customized mandibular orthotic may decrease the incidence of concussion/mild traumatic brain injuries in high- school football athletes, but a comprehensive study is required to confirm these initial findings. Furthermore, additional research is necessary to indicate the possible mode(s) of action of a customized mandibular orthotic in the prevention of concussion/mild traumatic brain injuries.

Tuesday, July 14, 2009

ADA Board proposes balanced budget, no dues hike for 2010

ADA Board proposes balanced budget, no dues hike for 2010
Posted July 13, 2009

By James Berry

In a message of solidarity to members contending with a down economy, the ADA Board of Trustees will send the House of Delegates a balanced budget proposal for 2010 and no recommended increase in membership dues.

The House will meet Oct. 2-6 at Annual Session in Hawaii.

"The [budget] process this year worked better than I've seen it in my time on the Board and as an officer" of the Association, said Dr. John S. Findley, ADA president. "The process worked because we recognized as a primary factor the economy and its effects on our members and the Association—and we realized we had to operate in a sound manner in that environment."

The 2010 budget proposal, prepared for the House as Board Report 2, balances revenues of $114,836,450 against equal expenses and seeks no increase in membership dues. With approval from the 2009 ADA House, annual dues for active members would remain at $498 in the coming year.

That would mean no dues increase for the second straight year, the House having rejected a proposed $14 increase last year. What's more, expenses in next year's proposed budget are $1,067,550 less than 2009 expenses approved by last year's House.

Dr. Edward Leone Jr., ADA treasurer, said he expects the House to be "receptive" to the budget proposal because of the effort that went into making it "as efficient as it can be, given the economic times."

He added, "The officers and trustees are all practicing dentists experiencing the economy in the same way as other dentists. We're not insulated or immune from any of that."

ADA Bylaws require that each year constituent (state and territorial) society leaders receive 90-day advance notice of any resolution affecting active member dues for the coming year and that they, in turn, share that notice with their delegates and alternate delegates to the ADA House.

This year's notice went to constituent executives June 26 in a joint memorandum from Drs. Findley and Kathleen O'Loughlin, ADA executive director. The ADA leaders note in the memo that the initial budget submissions from senior management projected a deficit of about $6 million.

"Through the collaborative effort of senior staff, guided by the Board, difficult choices were made to balance the budget," said Drs. Findley and O'Loughlin. "A theme of shared sacrifice permeated these decisions with the goal of not sacrificing key programs that benefit the membership and support the ADA's mission."

They added, "The state of the economy and its impact on our membership was the crucial factor in recommending that the dues rate for 2010 remain unchanged."

An administrative review committee encompassing the ADA president, president-elect, treasurer and four trustees scrutinized the division budgets and decision packages on new programs and advised senior management on areas that could be adjusted to bring down costs. (The executive director is a member of the review committee, but most of this activity took place before June 1, when Dr. O'Loughlin joined the staff.)

"The administrative review committee talked to senior staff about the adjustments they were recommending, accepting some and rejecting others," noted Dr. Leone. "The full Board then went through the very same exercise at its June meeting, reviewing the adjustments, accepting some, rejecting others. The Board also reviewed the decision packages; some were recommended, some were not."

Budget adjustments were made in all areas, with special emphasis on reducing travel expenses, meeting costs, consulting fees and outside services. The Board will complete its work on the budget at its August meeting. The report then goes to the delegates and alternates.

"Understanding the state of the economy, senior staff were very helpful and willing to suggest reductions in their areas to keep the ADA fiscally sound," said Dr. Ronald L. Tankersley, ADA president-elect.

He noted that "like most of our 401(k)s," the Association's reserves "took a hit" at the height of the economic downturn, but appear to be recovering slowly.

At the end of February, for example, reserves as a percentage of the budget were 24.1 percent. By the end of May, they had climbed to 31.2 percent, a gradual improvement but still well below the House-approved target of 50 percent.

"The trend is favorable, but we still have a way to go," said Dr. Leone.

The budget proposal, Board Report 2, remains only a draft until it is reviewed and approved by the House, which can alter it as it wishes. Dr. Tankersley, who will succeed Dr. Findley as president at annual session this fall, was asked what message he wished to convey to the House on the budget proposal.

"This is your organization," he replied. "The Board's responsibility is to represent you and promote your policies. We believe that this budget fulfills your wishes and our responsibilities, without endangering our short-term future.

"However, abandoning our dues stabilization process in the face of diminishing reserves and tremendous external challenges to our profession is a huge decision. So, if you feel that we need the financial resources to do more during these turbulent times, I'm sure the Board will be receptive."

The ADA, he added, is fiscally sound, and its leaders are doing what they believe is necessary to keep it that way.

Monday, July 13, 2009

GSK Releases New Science on Denture Care and Maintenance

www.dental-professional.com

GSK Releases New Science on Denture Care and Maintenance
New data presented at IADR/AADR General Session


PITTSBURGH – (July 8, 2009) –GlaxoSmithKline Consumer
Healthcare has released several new scientific studies addressing
the importance of proper denture care. Originally, presented at
the IADR/AADR/CADR 87th General Session in Miami, the studies
tested several GSK denture care products and addressed issues
such as minimizing fungal and bacterial attachment and activity on
dentures, reducing food-related denture stains as well as
enhancing a proper denture fit to increase patient satisfaction.

When taken as a whole, the results of the research conducted by
GSK along with doctors from the University Park Research
Center, University of Maryland and University of Buffalo School of
Dental Medicine show that GSK’s Polident® tablets are highly
effective in eliminating fungal and bacterial activity on dentures as
well as minimizing combination food-related denture stains while
saving both time and money. The studies also show that because
denture acrylic is susceptible to surface roughening, which
encourages bacterial attachment, it is recommended that Polident,
rather than toothpaste, be used as a cleaning agent to eliminate
denture scratching and assure effective cleaning. An additional
study also found Polident to be a safe and effective way to clean
and kill germs on orthodontic appliances.

In other studies presented at IADR/AADR, GSK examined proper
denture fit and patient satisfaction and found that even for well-
made and well-fitting dentures, the use of any one of GSK’s Super
PoliGrip® cream denture adhesives significantly improves denture
function and patient satisfaction. Areas such as retention,
stability, bite force and masticatory efficacy all significantly
improved when compared to using no adhesive. Likewise, patient
satisfaction and confidence also increased with the use of Super PoliGrip denture adhesives.

“These studies help show that utilizing Polident and Super PoliGrip are a benefit not only to effective
denture care and maintenance but to the patient’s overall satisfaction with their dentures,” said Eric
Sensky, GlaxoSmithKline Denture Care Brand Manager. “GlaxoSmithKline is dedicated to helping
dental professionals serve their patients and assist them with feeling comfortable and confident with
their dentures.”

The new data complements earlier research performed by GlaxoSmithKline Consumer Healthcare on
helping patients transition to life with new dentures and properly care for their dentures. Those studies
showed that use of Polident cleanser helped keep denture surfaces smooth, limiting the growth of
bacteria and helping to keep dentures odor-free. Another study on Super PoliGrip adhesive found the
product beneficial even for well-fitting dentures, with patients reporting increased confidence, comfort
and satisfaction when using the adhesive.

GlaxoSmithKline Consumer Healthcare, a leader in the development of denture care products, is
committed to raising awareness of the needs of edentulous patients. As part of that commitment, GSK
is proud to work with the leading researchers in edentulism studies to foster education and innovation.
By presenting these findings at the IADR/AADR, GSK hopes to make the most innovative and relevant
information accessible to dental professionals worldwide.

For more information about this data please visit www.dental-professional.com.

Friday, July 10, 2009

Prodrive Systems


I have tried the Prodrive system and it is the best cutting air drive handpiece around!
Check me out in the video and learn more about this remarkable handpiece on the Prodrive web site.

The ProDrive System
Designed as a performance upgrade to your current handpiece, the ProDrive System is the world’s first turbine and bur locking system proven to improve the performance in KaVo, Star and Midwest high-speed handpieces.

The ProDrive System is a fully compatible turbine upgrade allowing you to continue using your preferred handpiece, yet with a superior performance like never before.

The ProDrive System’s patented, triangular bur shank enables the turbine to lock the bur into place resulting in greater bur retention, providing superior torque transfer, smoother handpiece operation, and improved overall control.

Thursday, July 09, 2009

Consumer Reports on take home bleaching kits

Would you like whiter teeth but don't want to spend hundreds of dollars? Then you've probably considered a drugstore tooth whitener. But will any of them really whiten your teeth noticeably?

A new consumer investigation put eight top sellers to the test.

Read the Consumer Reports/ABC News bleaching results

Tuesday, July 07, 2009

MTA pulpotomy of human permanent molars with irreversible pulpitis

Here is a very interesting on article I thought you all might be interested in.

Australian Endodontic Journal
Volume 35 Issue 1, Pages 4 - 8

Published Online: 30 Mar 2009
Mohammad Jafar Eghbal, dds, ms; Saeed Asgary, dds, ms; Reza Ali Baglue, dds; Masoud Parirokh, dds, ms; and Jamileh Ghoddusi, dds, ms

ABSTRACT

The histological success of mineral trioxide aggregate (MTA) pulpotomy for treatment of irreversible pulpitis in human teeth as an alternative treatment was investigated in this study. Fourteen molars which had to be extracted were selected from patients 16–28 years old. The selection criteria include carious pulp exposure with a history of lingering pain. After isolation, caries removal and pulp exposure, MTA was used in pulpotomy treatment. Patients were evaluated for pain after 24 h. Two patients were lost from this study. Twelve teeth were extracted after 2 months and were assessed histologically. Recall examinations confirmed that none of the patients experienced pain after pulpotomy. Histological observation revealed that all samples had dentin bridge formation completely and that the pulps were vital and free of inflammation. Although the results favour the use of MTA as a pulpotomy material, more studies with larger samples and a longer recall period are suggested to justify the use of MTA for treatment of irreversible pulpitis in human permanent teeth.

Monday, July 06, 2009

GSK Educational Grant Helps Foster Education and Innovation in Caring for Edentulous Patients

PITTSBURGH – (July 1, 2009) –GlaxoSmithKline Consumer Healthcare announces the release of new data on the future of edentulism, highlighting the key roles dental professionals must play in providing quality oral healthcare and emotional support to denture patients. The research, funded through an educational grant from GlaxoSmithKline Consumer Healthcare, was originally presented at the Federation Dentaire International (FDI) World Congress and was recently published by the American College of Prosthodontists (ACP) in its March issue of the Journal of Prosthodontics.

The results of the research show the psychological impact the denture process can have on patients, and underscore the need for dental professionals to provide both emotional support and education throughout the process. The research, performed by doctors from the University of North Carolina School of Dentistry, the Mayo Clinic, Glasgow Dental Hospital and School, and the UCLA School of Dentistry, cites data showing that increasing life expectancies and the size of the aging population will result in a sustained demand for dentures over the coming years. While dental implants are becoming more popular, the researchers caution that not every patient is a good candidate and many cannot afford the procedure, meaning that dentures will remain an important treatment for edentulism.

“Dentistry has left a significant and growing number of patients behind,” writes Dr. Jonathan Ferencz in an introduction to the research within the Journal of Prosthodontics. Dr. Ferencz cites the increasing number of edentulous patients, lack of technological improvements to dentures, declining denture curriculum in schools, and practicing dentists’ loss of interest in the field as factors in a “perfect storm” that is threatening quality care.

Additional highlights from the work show that denture wearers are at risk for multiple oral and systemic disorders, reinforcing the need for careful treatment and regular recall visits. Furthermore, one paper outlines the serious emotional impact that receiving dentures can have on a patient’s life and concludes that determining patient expectations prior to treatment is critical. Additionally, data shows that use of a denture adhesive can help improve patient acceptance and adaptation to new dentures, easing the transition process for patients.

The new data complements earlier research performed by GlaxoSmithKline Consumer Healthcare on helping patients transition to life with dentures and properly care for them. Those studies showed that use of Polident® cleanser helped keep denture surfaces smooth, limiting the growth of bacteria and helping to keep dentures odor-free. Another study on Super PoliGrip® adhesive found the product beneficial even for well-fitting dentures, with patients reporting increased confidence, comfort and satisfaction when using the adhesive.


“As the baby boomer population ages, the demographics of denture patients are expected to shift, and it is imperative for dentists to be prepared to work with this changing population,” said Eric Sensky, GlaxoSmithKline Denture Care Brand Manager. “GlaxoSmithKline is dedicated to helping dental professionals serve these patients and assist them with feeling comfortable and confident with their dentures.”

GlaxoSmithKline Consumer Healthcare, a leader in the development of denture care products, is committed to raising awareness of the needs of edentulous patients. As part of that commitment, GSK is proud to work with the leading researchers in edentulism studies to foster education and innovation. By partnering with the ACP, GSK hopes to make the most innovative and relevant information accessible to dental professionals world wide.

For more information about this data please visit www.dental-professional.com.

Saturday, July 04, 2009


I want to thank the founding father's for the courage to go forward and to all those who have defended this country for the past 233 years.

IN CONGRESS, JULY 4, 1776
The unanimous Declaration of the thirteen united States of America

When in the Course of human events it becomes necessary for one people to dissolve the political bands which have connected them with another and to assume among the powers of the earth, the separate and equal station to which the Laws of Nature and of Nature's God entitle them, a decent respect to the opinions of mankind requires that they should declare the causes which impel them to the separation.

We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable Rights, that among these are Life, Liberty and the pursuit of Happiness. — That to secure these rights, Governments are instituted among Men, deriving their just powers from the consent of the governed, — That whenever any Form of Government becomes destructive of these ends, it is the Right of the People to alter or to abolish it, and to institute new Government, laying its foundation on such principles and organizing its powers in such form, as to them shall seem most likely to effect their Safety and Happiness. Prudence, indeed, will dictate that Governments long established should not be changed for light and transient causes; and accordingly all experience hath shewn that mankind are more disposed to suffer, while evils are sufferable than to right themselves by abolishing the forms to which they are accustomed. But when a long train of abuses and usurpations, pursuing invariably the same Object evinces a design to reduce them under absolute Despotism, it is their right, it is their duty, to throw off such Government, and to provide new Guards for their future security. — Such has been the patient sufferance of these Colonies; and such is now the necessity which constrains them to alter their former Systems of Government. The history of the present King of Great Britain is a history of repeated injuries and usurpations, all having in direct object the establishment of an absolute Tyranny over these States. To prove this, let Facts be submitted to a candid world.

He has refused his Assent to Laws, the most wholesome and necessary for the public good.

He has forbidden his Governors to pass Laws of immediate and pressing importance, unless suspended in their operation till his Assent should be obtained; and when so suspended, he has utterly neglected to attend to them.

He has refused to pass other Laws for the accommodation of large districts of people, unless those people would relinquish the right of Representation in the Legislature, a right inestimable to them and formidable to tyrants only.

He has called together legislative bodies at places unusual, uncomfortable, and distant from the depository of their Public Records, for the sole purpose of fatiguing them into compliance with his measures.

He has dissolved Representative Houses repeatedly, for opposing with manly firmness his invasions on the rights of the people.

He has refused for a long time, after such dissolutions, to cause others to be elected, whereby the Legislative Powers, incapable of Annihilation, have returned to the People at large for their exercise; the State remaining in the mean time exposed to all the dangers of invasion from without, and convulsions within.

He has endeavoured to prevent the population of these States; for that purpose obstructing the Laws for Naturalization of Foreigners; refusing to pass others to encourage their migrations hither, and raising the conditions of new Appropriations of Lands.

He has obstructed the Administration of Justice by refusing his Assent to Laws for establishing Judiciary Powers.

He has made Judges dependent on his Will alone for the tenure of their offices, and the amount and payment of their salaries.

He has erected a multitude of New Offices, and sent hither swarms of Officers to harass our people and eat out their substance.

He has kept among us, in times of peace, Standing Armies without the Consent of our legislatures.

He has affected to render the Military independent of and superior to the Civil Power.

He has combined with others to subject us to a jurisdiction foreign to our constitution, and unacknowledged by our laws; giving his Assent to their Acts of pretended Legislation:

For quartering large bodies of armed troops among us:

For protecting them, by a mock Trial from punishment for any Murders which they should commit on the Inhabitants of these States:

For cutting off our Trade with all parts of the world:

For imposing Taxes on us without our Consent:

For depriving us in many cases, of the benefit of Trial by Jury:

For transporting us beyond Seas to be tried for pretended offences:

For abolishing the free System of English Laws in a neighbouring Province, establishing therein an Arbitrary government, and enlarging its Boundaries so as to render it at once an example and fit instrument for introducing the same absolute rule into these Colonies

For taking away our Charters, abolishing our most valuable Laws and altering fundamentally the Forms of our Governments:

For suspending our own Legislatures, and declaring themselves invested with power to legislate for us in all cases whatsoever.

He has abdicated Government here, by declaring us out of his Protection and waging War against us.

He has plundered our seas, ravaged our coasts, burnt our towns, and destroyed the lives of our people.

He is at this time transporting large Armies of foreign Mercenaries to compleat the works of death, desolation, and tyranny, already begun with circumstances of Cruelty & Perfidy scarcely paralleled in the most barbarous ages, and totally unworthy the Head of a civilized nation.

He has constrained our fellow Citizens taken Captive on the high Seas to bear Arms against their Country, to become the executioners of their friends and Brethren, or to fall themselves by their Hands.

He has excited domestic insurrections amongst us, and has endeavoured to bring on the inhabitants of our frontiers, the merciless Indian Savages whose known rule of warfare, is an undistinguished destruction of all ages, sexes and conditions.

In every stage of these Oppressions We have Petitioned for Redress in the most humble terms: Our repeated Petitions have been answered only by repeated injury. A Prince, whose character is thus marked by every act which may define a Tyrant, is unfit to be the ruler of a free people.

Nor have We been wanting in attentions to our British brethren. We have warned them from time to time of attempts by their legislature to extend an unwarrantable jurisdiction over us. We have reminded them of the circumstances of our emigration and settlement here. We have appealed to their native justice and magnanimity, and we have conjured them by the ties of our common kindred to disavow these usurpations, which would inevitably interrupt our connections and correspondence. They too have been deaf to the voice of justice and of consanguinity. We must, therefore, acquiesce in the necessity, which denounces our Separation, and hold them, as we hold the rest of mankind, Enemies in War, in Peace Friends.

We, therefore, the Representatives of the united States of America, in General Congress, Assembled, appealing to the Supreme Judge of the world for the rectitude of our intentions, do, in the Name, and by Authority of the good People of these Colonies, solemnly publish and declare, That these united Colonies are, and of Right ought to be Free and Independent States, that they are Absolved from all Allegiance to the British Crown, and that all political connection between them and the State of Great Britain, is and ought to be totally dissolved; and that as Free and Independent States, they have full Power to levy War, conclude Peace, contract Alliances, establish Commerce, and to do all other Acts and Things which Independent States may of right do. — And for the support of this Declaration, with a firm reliance on the protection of Divine Providence, we mutually pledge to each other our Lives, our Fortunes, and our sacred Honor.

Friday, July 03, 2009

“Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals”

I recently signed up to attend an upcoming Novartis-sponsored dinner conference entitled “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals”. It is being given here in Central NJ and I thought it would be an interesting lecture. You may also be interested in this topic. The dinner conferences will be held in cities throughout the U.S. including Fort Lauderdale, FL; Jacksonville, FL; Eatontown, NJ; Uniondale, NY; Valley Forge, PA; Long Beach, CA; San Francisco, CA; Houston, TX and Chicago, IL.

The 2-hour program will be presented by a clinician expert on bisphosphonate therapy and will cover the following topics:

· Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic bone disease

* Osteonecrosis of the jaw (ONJ) background
* ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
* Review of ONJ studies and management

Full schedule details and online registration can be found at www.oralhealthdinnermeeting.com.

Thursday, July 02, 2009

Oral Helathcare Can't Wait

Here is a video that was shot at Mays California Dental Association meeting.
So click on the link and watch the video. I pop in the video at the 1:46 and 3:18 marks.

Oral Healthcare Can't Wait

Dental Trade Alliance Launches “Oral Healthcare Can’t Wait™” 
Awareness Campaign

Dental Industry Unites to Warn Consumers About the Risks of
Putting Off Regular Checkups and Recommended Treatment

Arlington, VA – July 1st, 2009 – The Dental Trade Alliance (DTA), a nonprofit trade association representing leading dental manufacturers, distributors, and laboratories, recently launched its “Oral Healthcare Can’t Wait™” awareness campaign (http://www.oralhealthcarecantwait.com) in an effort to warn consumers about the risks of postponing regular dental checkups and recommended treatment. According to DTA chief executive officer Gary Price, “The current economic climate is causing many people to either postpone the treatment plans recommended by their dentists, or to put off dental visits altogether.”

The potential health risks of postponing oral healthcare treatment can be significant, with more and more published research supporting the existence of a strong link between optimum oral health and overall well-being – especially in the area of periodontal disease. “But it doesn’t have to be this way,” explains Price. “Although we face economic challenges on a national basis, the majority of Americans still have the ability to make continued and comprehensive oral care an integrated part of their lives.”

Therefore, the DTA is launching a multifaceted Oral Healthcare Can’t Wait awareness campaign to dental professionals and consumers alike. Lanmark Group, the dental industry’s leading advertising, marketing, and public relations agency, will be spearheading this effort by developing the overall strategy, creative concepts, and tactical execution on a pro bono basis. The following is just a partial outline of the campaign marketing components that Lanmark is currently providing:

Oral Healthcare Can’t Wait logo and slogan
Dedicated Oral Healthcare Can’t Wait website for dental professionals and consumers
Dental trade and consumer print and online advertising
Professional and consumer public relations program
Public service announcements
Patient education brochures and posters
Dental practice marketing tool kit to promote “Oral Healthcare Can’t Wait” campaign in local markets
Online video for distribution via YouTube, etc.


“Oral Healthcare Can’t Wait promises to be a very ambitious campaign, with the ultimate goal being to sustain and improve oral health in America,” explained Price. “I’m very grateful for the level of commitment and agency resources that Lanmark president Howard Klein has pledged to this campaign, as well as the support of our leading dental industry publications, such as Compendium, Dental Economics, Dental Product Report, Dental Product Shopper, Dentistry Today, Dental Tribune, DentalTown, Dimensions of Dental Hygiene, Inside Dentistry, and RDH Magazine. In addition, the leading dental distributors Benco Dental, Burkhart Dental Supply, Darby Dental Supply, Henry Schein, Iowa Dental Supply and Patterson Dental have pledged their support to help launch this important initiative. We will also be counting on the support of DTA members in other areas, such as funding for direct-to-consumer advertising in national newspapers, television, and radio, etc. If we work together, we can make a difference.” For more information regarding the Oral Healthcare Can’t Wait Campaign, visit http://www.oralhealthcarecantwait.com. To pledge support, contact Dental Trade Alliance CEO Gary Price at 703.379.7755.